Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Christoper Bragg, Ph.D.

Co-Author

This page shows the publications co-authored by David Bragg and Xandra Breakefield.
Connection Strength

1.544
  1. Inhibition of N-linked glycosylation prevents inclusion formation by the dystonia-related mutant form of torsinA. Mol Cell Neurosci. 2004 Dec; 27(4):417-26.
    View in: PubMed
    Score: 0.312
  2. TorsinA and early-onset torsion dystonia. Adv Neurol. 2004; 94:87-93.
    View in: PubMed
    Score: 0.293
  3. Perinuclear biogenesis of mutant torsin-A inclusions in cultured cells infected with tetracycline-regulated herpes simplex virus type 1 amplicon vectors. Neuroscience. 2004; 125(3):651-61.
    View in: PubMed
    Score: 0.293
  4. Disease onset in X-linked dystonia-parkinsonism correlates with expansion of a hexameric repeat within an SVA retrotransposon in TAF1. Proc Natl Acad Sci U S A. 2017 12 19; 114(51):E11020-E11028.
    View in: PubMed
    Score: 0.193
  5. Decreased N-TAF1 expression in X-linked dystonia-parkinsonism patient-specific neural stem cells. Dis Model Mech. 2016 Apr; 9(4):451-62.
    View in: PubMed
    Score: 0.169
  6. Molecular pathways in dystonia. Neurobiol Dis. 2011 May; 42(2):136-47.
    View in: PubMed
    Score: 0.118
  7. Dystonia-causing mutant torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamics. Neurobiol Dis. 2006 Apr; 22(1):98-111.
    View in: PubMed
    Score: 0.084
  8. Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation. J Neurosci. 2005 Jun 01; 25(22):5351-5.
    View in: PubMed
    Score: 0.081
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.